Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fibro-Vein 0.5% (10 mg/2 mL) injection, 5 x 2 mL ampoules |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 0.5% (10 mg/2 mL) injection, 2 mL ampoule |
Is a |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 0.5% (10 mg/2 mL) injection, 5 x 2 mL ampoules |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 1% (20 mg/2 mL) injection, 2 mL ampoule |
Is a |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 1% (20 mg/2 mL) injection, 5 x 2 mL ampoules |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein (sodium tetradecyl sulfate 60 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) |
Is a |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 3% (60 mg/2 mL) injection, 5 x 2 mL ampoules |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 0.2% (10 mg/5 mL) injection, 5 mL vial |
Is a |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 0.2% (10 mg/5 mL) injection, 10 x 5 mL vials |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 3% (150 mg/5 mL) injection, 5 mL vial |
Is a |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 3% (150 mg/5 mL) injection, 10 x 5 mL vials |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 0.2% (10 mg/5 mL) injection, 10 x 5 mL vials |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 3% (150 mg/5 mL) injection, 10 x 5 mL vials |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 1% (20 mg/2 mL) injection, 5 x 2 mL ampoules |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|
Fibro-Vein 3% (60 mg/2 mL) injection, 5 x 2 mL ampoules |
has TP |
True |
Fibro-Vein |
Inferred relationship |
Some |
|